Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.
Odiyoor
Mahesh
M
Kobylecki
Christopher
C
Hackett
Richard J
RJ
Silverdale
Monty A
MA
Kellett
Mark W
MW
D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D052160:Benzothiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D005783:Gender Identity; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D010641:Phenotype; D000077487:Pramipexole; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced* / Q000150:complications*
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D000077487:Pramipexole